Sheel Biotech Ltd
Incorporated in November 199, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
- Market Cap ₹ 111 Cr.
- Current Price ₹ 54.4
- High / Low ₹ 95.6 / 37.8
- Stock P/E 9.42
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 15.7 %
- ROE 14.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 20.1% CAGR over last 5 years
- Promoter holding has increased by 1.04% over last quarter.
Cons
- The company has delivered a poor sales growth of 11.8% over past five years.
- Company has high debtors of 183 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Diversified Commercial Services
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 63 | 84 | 89 | 103 | 110 | 110 | |
| 56 | 78 | 80 | 89 | 95 | 94 | |
| Operating Profit | 7 | 6 | 9 | 14 | 15 | 16 |
| OPM % | 10% | 8% | 10% | 14% | 14% | 15% |
| 0 | 0 | 0 | 0 | 1 | 1 | |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 5 | 6 | 12 | 13 | 14 |
| Tax % | 0% | 2% | 20% | 15% | 17% | 16% |
| 5 | 5 | 5 | 10 | 11 | 12 | |
| EPS in Rs | 11.58 | 10.88 | 12.26 | 25.27 | 7.12 | 5.78 |
| Dividend Payout % | 0% | 28% | 25% | 12% | 14% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 7% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 32% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 14% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 15 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 69 |
| 21 | 24 | 19 | 24 | 17 | 27 | |
| 4 | 10 | 11 | 10 | 12 | 13 | |
| Total Liabilities | 82 | 93 | 94 | 106 | 113 | 124 |
| 8 | 8 | 8 | 7 | 7 | 7 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| 75 | 84 | 85 | 98 | 105 | 116 | |
| Total Assets | 82 | 93 | 94 | 106 | 113 | 124 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 2 | 9 | -1 | 9 | -18 | ||
| -2 | -2 | -0 | -2 | -7 | ||
| -0 | -7 | 2 | -7 | 26 | ||
| Net Cash Flow | -0 | -0 | 0 | -0 | 2 | |
| Free Cash Flow | 1 | 8 | -1 | 8 | -24 | |
| CFO/OP | 37% | 105% | 3% | 75% | -94% |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 182 | |
| Inventory Days | 55 | 120 | 177 | 263 | 272 | |
| Days Payable | 30 | 85 | 75 | 37 | 29 | |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 426 | |
| Working Capital Days | 348 | 274 | 255 | 256 | 253 | |
| ROCE % | 7% | 10% | 15% | 14% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Production Capacity of Tissue Culture Planting Materials Million units per annum |
|
||
| Geographic Presence (States in India) Number |
|||
| Number of Farmer Producer Organizations (FPOs) Managed Number |
|||
Extracted by Screener AI
Documents
Announcements
-
Disclosure under SEBI Takeover Regulations
5 June 2026 - Sheel Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, …
-
Outcome of Board Meeting
28 May 2026 - Board approved audited standalone results for FY26; IPO funds of ₹34.02 crore raised, ₹2.74 crore unutilised.
-
Updates
20 May 2026 - Sheel Biotech Limited has informed regarding 'Intimation of Signing of Memorandum of Understanding Indian Council of Agricultural Research (ICAR) CISH'.
- Monitoring Agency Report 20 May 2026
-
Structural Digital Database
6 May 2026 - Compliance certificate for FY 2025-26 confirms SDD in place; nil noncompliance.
Business Profile[1]
The company is engaged in the cultivation, development, processing, and supply of plants across multiple categories, including field crops, fruits, vegetables, and ornamental plants. Tissue culture techniques and organic farming practices drive its operations.